Tri-estarylla Kit
Product Images NDC 63629-2350

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tri-estarylla (NDC 63629-2350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 2

A forest plot showing effect estimates (odds ratios or relative risks) and confidence intervals from multiple cohort studies on contraceptive use. Each study is listed on the left with corresponding effect estimates and confidence intervals plotted on the right along a horizontal axis labeled 'Effect Estimate (OR/RR)' ranging from -1.5 to 2. Studies include NICHD, French E3N, Shanghai Women's, Nurses' Health, Oxford Family Planning, and Danish Sex Hormone Register cohorts, with some data for ever use and current use.*

FDA Label Image

Chemical Structure 1 (B4ca5260 1e51 4bfd A22e Fd2595f1f812 02)

Chemical structure of norgestimate, an active ingredient found in the medication Tri-Estarylla (norgestimate and ethinyl estradiol). The diagram shows the molecular composition and bonding arrangement characteristic of this synthetic hormone.*

FDA Label Image

Chemical Structure 2 (B4ca5260 1e51 4bfd A22e Fd2595f1f812 03)

Chemical structure of ethinyl estradiol, an active ingredient in the prescription drug Tri-Estarylla. The diagram shows the molecular arrangement including functional groups and rings characteristic of ethinyl estradiol.*

FDA Label Image

Figure (B4ca5260 1e51 4bfd A22e Fd2595f1f812 04)

An illustration showing a vertical scale indicating pregnancy rates from fewer than 1 to 85 or more pregnancies per 100 women in one year. Various birth control methods are categorized along the scale by effectiveness: implants, injections, intrauterine devices, and sterilization at the top with fewer pregnancies; birth control pills, skin patch, and vaginal ring with hormones; condoms and diaphragm; no sex during fertile days, spermicide, and withdrawal; and no birth control at the bottom with most pregnancies.*

FDA Label Image

Label (Lbl636292350)

Tri-Estarylla kit contains norgestimate and ethinyl estradiol tablets. The label details three types of tablets by dosage: white tablets with 0.18 mg norgestimate and 0.035 mg ethinyl estradiol, light blue tablets with 0.215 mg norgestimate and 0.035 mg ethinyl estradiol, and blue tablets with 0.25 mg norgestimate and 0.035 mg ethinyl estradiol. Green tablets contain only inert ingredients. The package holds 84 tablets in 3 blister cards of 28 tablets each. Labeler is Bryant Ranch Prepack, NDC 63629-2350.*

FDA Label Image

Tri-estar (Tri Estar)

Tri-Estarylla medication pack label showing a 28-day dosing calendar with four rows representing weeks 1 to 4. The active tablets for the first three weeks are round and unshaded, while the Week 4 tablets are round and shaded, indicating inactive pills. The label includes the drug's generic names, norgestimate and ethinyl estradiol, with listed dosages per tablet. The pack is designed as a kit by Bryant Ranch Prepack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.